evipedia.ai
← Back

Iberin for Health & Longevity

Evidence Review created on 10/23/2026 using AI4L / Opus 5.5

Also known as: 3-methylsulfinylpropyl isothiocyanate, 1-isothiocyanato-3-(methylsulfinyl)propane, IMSP, IBN

Motivation

Iberin is a sulfur-containing plant compound released when cabbage, kale, Brussels sprouts, broccoli or horseradish are cut or chewed. It is a close chemical relative of sulforaphane, the better-known broccoli compound, and differs from it by a single carbon atom. Like its relative, it is thought to switch on the body’s own antioxidant and detoxification defenses, which makes it of interest to people who use diet to support long-term health.

Interest in iberin grew out of long-running research into the health effects of cabbage-family vegetables. Laboratory groups have studied it in cancer cells, in inflammation and in bacterial communication, while nutrition scientists have measured how much of it the body absorbs from vegetables prepared in different ways.

This review examines the human, animal and laboratory evidence on iberin’s potential benefits and risks, how it can be obtained through food or supplements, and what remains unknown. It is written for health- and longevity-focused adults who want to judge a compound that has been studied far less than its famous relative.

Benefits - Risks - Protocol - Conclusion

This section lists expert overviews of the closely related compound sulforaphane plus key iberin laboratory and human studies.

Only Rhonda Patrick (FoundMyFitness), Chris Kresser and Life Extension Magazine had directly relevant content, and all three address sulforaphane rather than iberin. Searches of Peter Attia, Andrew Huberman and Lifespan.io found no content discussing iberin or a dedicated sulforaphane overview.

Grokipedia

No Grokipedia article on iberin exists.

Examine

No Examine article on iberin exists.

ConsumerLab

No ConsumerLab article on iberin exists.

Systematic Reviews

No systematic reviews or meta-analyses for Iberin were found on PubMed as of October 23, 2026.

Mechanism of Action

Iberin is not stored in plants as such. Myrosinase (a plant or gut-bacterial enzyme) releases it from its precursor glucoiberin when cabbage, kale, broccoli or horseradish tissue is crushed. Its reactive isothiocyanate group binds sulfur-containing cysteine sites on proteins.

  • Nrf2 activation: Binding to Keap1 (the protein that holds Nrf2 inactive) frees Nrf2 to switch on HO-1 (heme oxygenase-1, an antioxidant enzyme) and TrxR1 (thioredoxin reductase 1, a redox-balancing enzyme) in cell studies (Ernst et al., 2013; Wang et al., 2005).
  • Inflammation signaling: Iberin covalently blocks pairing of TLRs (toll-like receptors, immune sensors of microbial products), dampening NF-κB (nuclear factor kappa B, a master inflammation switch) (Shibata et al., 2014).
  • Competing pro-oxidant reading: In cancer cells iberin depletes glutathione (the main cellular antioxidant) and raises ROS (reactive oxygen species), triggering apoptosis (programmed cell death) (Gong et al., 2021); benefits may stem from brief beneficial stress rather than direct antioxidant action.
  • Pharmacology: Iberin is not selective; it reacts with many proteins. GSTs (glutathione S-transferases, conjugating enzymes) route it into N-acetylcysteine conjugates excreted in urine (Al Janobi et al., 2006), with an excretion half-life near 2.5 hours (Oliviero et al., 2014). It inhibited none of six CYP (cytochrome P450, drug-metabolizing) enzymes in human liver tissue (Elbarbry et al., 2024). Human tissue distribution is uncharacterized; gut bacteria can divert glucoiberin to inactive iberin-nitrile (Bouranis et al., 2021).

Historical Context & Evolution

  • Original use: Iberin takes its name from Iberis (candytuft), a cabbage-family genus. Bitter candytuft (Iberis amara) has a long European folk use for digestive complaints and is an ingredient of the herbal digestive combination Iberogast, as described in a plant profile (Reichling & Saller, 2002). Iberin itself was known only as a pungent mustard-oil compound, not a remedy.
  • Path to health interest: In 1992 Johns Hopkins researchers isolated sulforaphane from broccoli as a potent inducer of detoxification enzymes and compared synthetic homologues, including the three-carbon iberin; sulforaphane proved most potent (Zhang et al., 1992).
  • Early safety work: Rat studies in 1993 found gastric erosions only at high single doses and no liver or kidney lesions (Kore & Wallig, 1993).
  • Laboratory expansion: From 2005, cell studies reported antioxidant-enzyme (Wang et al., 2005) and anticancer activity, and in 2012 activity against quorum sensing (the chemical signaling bacteria use to coordinate group behavior) (Jakobsen et al., 2012).
  • Human data: Since 2006, human studies have measured iberin metabolites after broccoli meals (Al Janobi et al., 2006); in 2015 a broccoli bred for higher glucoraphanin (sulforaphane’s inactive plant precursor), also richer in glucoiberin, was tested on cholesterol by the group led by the inventor named on its breeding patent (Armah et al., 2015).
  • How opinion shifted: The 1992 ranking cast iberin as a weaker sulforaphane; a 2013 head-to-head cell study found similar Nrf2 potency (Ernst et al., 2013). Neither view rests on human outcome data.

Expected Benefits

High 🟩 🟩 🟩

No benefit reaches High: no trial has tested purified iberin, and the only human outcome data come from glucoiberin-containing broccoli or cruciferous-vegetable intake, which is indirect evidence.

Medium 🟩 🟩

No benefit reaches Medium: the controlled and observational human data tested whole vegetables containing many compounds besides iberin, so they are indirect and capped at Low.

Low 🟩

Lower Low-Density Lipoprotein Cholesterol ⚠️ Conflicted

Two randomized trials led by Mithen, the cultivar’s patent inventor, found high-glucoraphanin broccoli lowered LDL-C (low-density lipoprotein cholesterol). Indirect: glucoiberin’s effect is inseparable from sulforaphane’s. A meta-analysis of nine Brassica trials found no significant LDL-C change (Darand et al., 2022), plausibly because vegetables and doses differed. Net: an unconfirmed reduction.

Magnitude: LDL-C fell 7.1% (95% CI, the range likely to contain the true value: 1.8–12.3%) and 5.1% (2.1–8.1%) within the high-glucoraphanin groups versus 1.8% and 2.5% with standard broccoli; the pooled between-group comparison was significant (p = 0.031, the probability of a chance finding) without a reported difference figure (Armah et al., 2015).

Lower All-Cause Mortality

A meta-analysis of prospective cohorts found higher cruciferous-vegetable intake associated with lower all-cause mortality. Evidence is indirect and observational: crucifers deliver iberin alongside sulforaphane, fiber, vitamins and other compounds, and healthier lifestyles may confound the association.

Magnitude: Highest versus lowest intake RR (relative risk) 0.88 (95% CI 0.80–0.97); per 100 g/day RR 0.90 (95% CI 0.85–0.95) (Aune et al., 2017).

Lower Total Cancer Risk ⚠️ Conflicted

The same meta-analysis linked higher cruciferous intake to lower total cancer risk; the dose-response estimate was nonsignificant. Evidence is indirect and observational; in cell studies iberin killed neuroblastoma (nerve-tissue cancer) and ovarian cancer cells (Jadhav et al., 2007; Gong et al., 2021). Net: an inconsistent association not attributable to iberin.

Magnitude: Highest versus lowest intake RR 0.84 (95% CI 0.72–0.97); per 100 g/day RR 0.91 (95% CI 0.82–1.02) (Aune et al., 2017).

Speculative 🟨

Antioxidant Enzyme Induction

Iberin activated Nrf2 about as potently as sulforaphane in mouse cells (Ernst et al., 2013) and raised detoxifying enzymes in rat bladder and gut (Munday & Munday, 2004). Cell and animal data only.

Reduced Inflammatory Signaling

Cabbage-derived iberin blocked TLR pairing (Shibata et al., 2014) and lowered IL-6 (interleukin-6, an inflammatory messenger) in stimulated human oral cells (Hosokawa et al., 2022). Cell data only.

Anti-Virulence Against Pseudomonas aeruginosa

Iberin suppressed quorum-sensing genes, virulence factors and biofilm (protective bacterial slime layer) formation in Pseudomonas aeruginosa cultures (Jakobsen et al., 2012; Tan et al., 2014). Laboratory data only; no infection studies exist.

Kidney Protection After Ischemia-Reperfusion

Iberin pretreatment reduced inflammatory and cell-death markers after ischemia-reperfusion (blood flow cut off, then restored) of rat kidneys (Yahiya et al., 2023). Single small animal study.

Benefit-Modifying Factors

  • Genetic polymorphisms: People lacking the GSTM1 gene (glutathione S-transferase mu 1, an enzyme conjugating isothiocyanates) had higher plasma sulforaphane-metabolite levels and faster urinary excretion after broccoli (Gasper et al., 2005); iberin shares this pathway, so exposure likely differs by genotype, though iberin-specific data are lacking.
  • Gut microbiome: Fecal microbiomes differed widely in how much glucosinolate they converted to inactive nitriles (Bouranis et al., 2021); in a sprout-extract trial by sulforaphane patent holders, responders carried more bacterial genes for isothiocyanate release (Dwibedi et al., 2025).
  • Baseline biomarkers: In adults at moderate cardiovascular risk, the LDL-C fall with high-glucoraphanin broccoli did not depend on baseline LDL-C, whereas the smaller standard-broccoli effect appeared mainly at higher baseline levels (Armah et al., 2015).
  • Sex: In the high-glucoraphanin broccoli trials, the LDL-C reduction showed no significant association with sex (Armah et al., 2015); no sex-specific data exist for purified iberin.
  • Pre-existing conditions: In prediabetes, sprout-extract benefits concentrated in a metabolic subgroup (Dwibedi et al., 2025); conditions affecting gut flora or absorption may reduce iberin release.
  • Age: No age-specific data; older adults with lower intake of raw crucifers or altered gut flora may release less iberin from food.
  • Food preparation: Complete myrosinase inactivation cut urinary iberin recovery to 19% of glucoiberin intake (Oliviero et al., 2014).

Potential Risks & Side Effects

High 🟥 🟥 🟥

No risk reaches High: there are no human safety data for iberin itself, and the human adverse-event data come from sulforaphane products, which are indirect evidence.

Medium 🟥 🟥

No risk reaches Medium: the human adverse-event trials tested sulforaphane rather than iberin, and iberin-specific harms are documented only in rat and cell studies.

Low 🟥

Gastrointestinal Upset ⚠️ Conflicted

Concentrated isothiocyanates cause nausea, abdominal discomfort and loose stools, likely via gut-lining irritation. Indirect evidence: sulforaphane trials by Clack (developer-sponsored) and Dwibedi et al., 2025; high-dose rat gastric erosions (Kore & Wallig, 1993). A low-dose trial by sprout-extract developers found no consistent toxicity (Shapiro et al., 2006). Net: dose-dependent effects.

Magnitude: Abdominal discomfort in 17 of 18 participants (94%) on stabilized sulforaphane versus 0 of 6 on placebo; nausea in 56% versus 0% (Clack et al., 2025).

Thyroid Function Interference ⚠️ Conflicted

Isothiocyanates are long-suspected goitrogens (substances that can suppress thyroid hormone production). Randomized broccoli sprout trials by Chartoumpekis and by Shapiro, whose team included a sprout-extract company co-founder, found no change in thyroid tests; evidence is indirect (sulforaphane-rich products). Net: no human thyroid signal at studied doses.

Magnitude: No effect detected: TSH (thyroid-stimulating hormone; treatment-by-time p = 0.70), free thyroxine (p = 0.41) and thyroglobulin (a thyroid storage protein) did not change over 84 days versus placebo; the trial reports no effect-size figure (Chartoumpekis et al., 2019; Shapiro et al., 2006).

Allergic Reactions to Cabbage-Family Foods

Allergy to mustard and other cabbage-family foods can cause hives, swelling and anaphylaxis (a severe whole-body allergic reaction), documented in a food-challenge series (Figueroa et al., 2005) and an umbrella review (Li et al., 2022). Indirect: the allergens are plant proteins, not iberin, but accompany food sources and mustard-powder protocols.

Magnitude: Systemic anaphylaxis was reported by 10.5% of 38 mustard-allergic patients (no control group; rate reported for the patient series only, not for the study’s paired controls) (Figueroa et al., 2005).

Speculative 🟨

Cytotoxicity and DNA Damage at High Concentrations

Above its half-maximal growth-inhibiting concentration, iberin caused DNA-damage marking, necrosis (uncontrolled cell death) and apoptosis in colon cells (Jakubikova et al., 2006). Basis is in-vitro only; dietary tissue levels are unknown.

Altered Drug-Metabolizing Enzymes

Aliphatic isothiocyanates including iberin repressed CYP1A and CYP3A2 in rat liver cells (La Marca et al., 2012), although iberin did not inhibit human CYP enzymes. Mechanistic data only.

Risk-Modifying Factors

  • Genetic polymorphisms: People lacking the GSTM1 gene showed higher plasma sulforaphane-metabolite levels (Gasper et al., 2005); if iberin behaves similarly, higher exposure could raise gastrointestinal effects from concentrated products (inferred, not tested).
  • Baseline biomarkers: Elevated baseline TSH or low iodine intake is the theoretical setting in which goitrogenic effects would matter most; trials enrolled people with mostly normal thyroid function.
  • Sex: The thyroid analysis of the 12-week broccoli sprout beverage trial included only women (Chartoumpekis et al., 2019); the stabilized-sulforaphane tolerability trial enrolled only men (Clack et al., 2025).
  • Pre-existing conditions: Peptic ulcer, erosive gastritis or inflammatory bowel disease may increase vulnerability to gastric irritation (theoretical, from rat data); treated or untreated hypothyroidism remains untested.
  • Age: Older adults taking several medications face more potential enzyme-mediated interactions; no age-specific safety data exist.

Key Interactions & Contraindications

Prescription drugs

  • Narrow-margin CYP-metabolized drugs (warfarin, tacrolimus, cyclosporine): Monitor (theoretical). Iberin inhibited no human CYP enzyme in liver microsomes (Elbarbry et al., 2024), but iberin repressed rat CYP3A2 (La Marca et al., 2012); consequence: altered drug levels; mitigation: drug-level or clotting-test checks after starting concentrates.
  • Warfarin (via vitamin K–rich foods): Monitor. The warfarin product label states dietary vitamin K affects therapy; an umbrella review notes broccoli-related warfarin resistance (Li et al., 2022). Consequence: reduced anticoagulation; mitigation: steady crucifer intake and INR (international normalized ratio, a clotting test) checks.
  • Chemotherapy drugs (docetaxel, cisplatin): Caution (theoretical). Iberin increased chemotherapy sensitivity in cancer cells (Núñez-Iglesias et al., 2019; Gong et al., 2021); consequence: possibly altered chemotherapy efficacy or toxicity, untested in humans; mitigation: pausing concentrated products during treatment cycles.
  • Thyroid hormone replacement (levothyroxine): Monitor (theoretical). Thyroid tests were unchanged with broccoli sprout beverage (Chartoumpekis et al., 2019), but concentrated isothiocyanates are untested in treated hypothyroidism; consequence: possible dose drift; mitigation: TSH recheck after starting.
  • UGT1A1-cleared drugs (irinotecan): Monitor (theoretical). Iberin raised UGT1A1 (a liver and gut conjugating enzyme) messenger RNA (the gene’s working copy) in colon cells (Jakubikova et al., 2006); faster clearance could lower drug exposure; mitigation: avoiding concentrated products during irinotecan treatment.

Over-the-counter medications

  • NSAIDs (non-steroidal anti-inflammatory drugs: ibuprofen, naproxen, aspirin): Caution (theoretical). Additive gastric irritation; high-dose iberin caused gastric erosions in rats (Kore & Wallig, 1993). Mitigation: taking both with food.
  • Acetaminophen (paracetamol): Monitor (theoretical). Acetaminophen is cleared partly by UGT and GST conjugation, which iberin induced in colon cells (Jakubikova et al., 2006); consequence: possibly altered clearance; no human study exists; mitigation: avoiding concentrated products during regular acetaminophen use.

Supplements

  • Other isothiocyanate supplements (sulforaphane, broccoli sprout extract, phenethyl isothiocyanate from watercress): Caution (theoretical); additive. Stacking raises total isothiocyanate dose; gastrointestinal events were frequent at concentrated sulforaphane doses (Clack et al., 2025). Mitigation: one concentrated product at a time.
  • Selenium: Monitor (theoretical); additive. Selenium amplified isothiocyanate-induced TrxR1 protein and activity in cells (Wang et al., 2005; Barrera et al., 2012); consequence: stronger antioxidant-enzyme response; mitigation: keeping total selenium below the tolerable upper intake level.

Other interventions

  • Antibiotics for Pseudomonas infections (meropenem, gentamicin): Monitor (theoretical); potentiating. Iberin-containing horseradish extracts increased antibiotic susceptibility of a multidrug-resistant Pseudomonas aeruginosa isolate in vitro (Stanisavljević et al., 2026); no human data.

Populations who should avoid Iberin:

  • People with known allergy or hypersensitivity to Brassica vegetables, flagged in an umbrella review (Li et al., 2022)
  • Pregnant or breastfeeding individuals, for concentrated or purified forms (no safety data)
  • People with active peptic ulcer or erosive gastritis, for concentrated forms (theoretical; rat gastric erosions, Kore & Wallig, 1993)
  • People with untreated hypothyroidism or iodine deficiency, for concentrated forms (theoretical)

Risk Mitigation Strategies

Doses and timings below follow common practice unless cited.

  • Food-first sourcing: Obtaining iberin from cabbage, kale, Brussels sprouts or broccoli rather than research-grade chemicals avoids untested doses and unverified purity, the main unknowns given no human safety data on purified iberin.
  • Gradual introduction: Raising raw crucifer or sprout-extract intake over 1–2 weeks limits the nausea and loose stools reported with concentrated isothiocyanates (Clack et al., 2025).
  • Taking with meals: Consuming crucifers or extracts with food reduces direct contact with the stomach lining, mitigating the gastric irritation seen at high doses in rats (Kore & Wallig, 1993).
  • No isothiocyanate stacking: Using one concentrated isothiocyanate product at a time prevents cumulative gastrointestinal adverse events.
  • Thyroid check in at-risk users: TSH and free thyroxine at baseline and 3 months in people with thyroid disease or low iodine intake detect the theoretical goitrogenic effect; concentrated products stop if TSH exceeds the reference range.
  • Steady intake with warfarin: Keeping crucifer intake consistent and checking INR within 1–2 weeks of dietary changes prevents loss of anticoagulation from vitamin K in iberin-rich foods, as reported in an umbrella review (Li et al., 2022).
  • Gastrointestinal stop rule: Pausing concentrated products if vomiting or diarrhea persists beyond 2–3 days limits dehydration and electrolyte loss from isothiocyanate-related gut irritation.

Therapeutic Protocol

Each dose below is cited to its source; other parameters without a citation (timing, splitting, titration) reflect common practice.

  • No established iberin dose: No human trial has given purified iberin, which is sold only as a research chemical. Rats given up to 100 µmol/kg/day for 7 days showed no lesions (Kore et al., 1993).
  • Whole-food regimen (Mithen group, Quadram Institute): 400 g/week of high-glucoraphanin broccoli, carrying about six-fold more glucoiberin than standard broccoli (4.5 versus 0.7 µmol/g dry weight), for 12 weeks (Armah et al., 2015).
  • Myrosinase rescue for cooked crucifers: 1 g powdered brown mustard added to 200 g cooked broccoli raised urinary sulforaphane metabolites more than four-fold (Okunade et al., 2018); the same enzyme releases iberin from glucoiberin.
  • Broccoli sprout extract (Talalay–Fahey approach, Johns Hopkins; popularized by Rhonda Patrick): Extracts deliver mainly sulforaphane with minor iberin; trial dose 150 µmol sulforaphane once daily for 12 weeks (Dwibedi et al., 2025).
  • Competing approaches: Food-first intake and concentrated sprout extracts are the two available routes; neither has been compared head-to-head for iberin exposure or outcomes.
  • Time of day: No timing study exists; intake with a main meal containing some fat is common, since lipids appeared to aid isothiocyanate absorption in a review of human studies (Narra et al., 2025).
  • Half-life: Urinary excretion half-life of iberin conjugates is about 2.5 hours (Oliviero et al., 2014); mixed broccoli sprout isothiocyanates showed a plasma half-life of 1.8 hours (Ye et al., 2002).
  • Single versus split intake: Given the short half-life, spreading crucifer servings across two or three meals sustains exposure; no trial has compared schedules.
  • Genetic polymorphisms: GSTM1 genotype altered sulforaphane handling (Gasper et al., 2005); genotype-guided iberin intake is untested.
  • Sex differences: The LDL-C response to high-glucoraphanin broccoli did not differ by sex (Armah et al., 2015); no sex-specific dosing data exist.
  • Age: No age-specific data; for older adults on several medications, food sources carry less interaction uncertainty than concentrated extracts.
  • Baseline biomarkers: The LDL-C fall with high-glucoraphanin broccoli did not depend on baseline LDL-C (Armah et al., 2015); baseline TSH frames thyroid safety in at-risk users.
  • Pre-existing conditions: Gastrointestinal disorders raise the irritation potential of concentrated extracts relative to food sources; gut-flora differences shaped response in prediabetes (Dwibedi et al., 2025).

Discontinuation & Cycling

  • Lifelong or short-term: Eating iberin-containing vegetables is a lifelong dietary pattern; concentrated-product trials lasted 7 days to 12 weeks, so long-term use of concentrates is untested.
  • Withdrawal effects: None reported for isothiocyanates in human trials; stopping removes exposure within about a day given the short half-life.
  • Tapering: Not needed; abrupt stopping carries no known rebound.
  • Cycling: No evidence that cycling preserves Nrf2 responsiveness; no study has compared continuous with intermittent iberin exposure.

Sourcing and Quality

  • No iberin supplement: Purified iberin, often the natural R-enantiomer (mirror-image form), is sold by chemical suppliers labeled not for human or veterinary use, without food-grade manufacturing, stability or dosing information.
  • Food sources: Glucoiberin occurs in cabbage-family vegetables; iberin has been isolated from cabbage (Shibata et al., 2014) and horseradish root (Jakobsen et al., 2012), and sprouting broccoli is a notable source (Chambers et al., 2009).
  • High-glucoraphanin broccoli (Beneforté): Carries more glucoiberin than standard broccoli (Armah et al., 2015); its breeding method was patented with Mithen as named inventor (US 6,340,784, now expired), and Mithen led the cholesterol trials.
  • Broccoli sprout supplements: Products with active myrosinase or preformed isothiocyanates and third-party testing (NSF International, USP – United States Pharmacopeia) are the available quality markers; glucoiberin is rarely declared. Avmacol (Nutramax Laboratories) is used in a registered trial (NCT05121051).
  • Fermented cabbage: Myrosinase-positive bacteria can form iberin during fermentation (Luang-In et al., 2018), but yields vary.
  • Bitter candytuft products: Iberis amara is used as a whole fresh-plant extract in the herbal combination Iberogast and contains mustard-oil glycosides among other constituents (Reichling & Saller, 2002); no iberin content is declared for such products.

Practical Considerations

  • Time to effect: Urinary iberin conjugates peak 2.3–6.1 hours after broccoli (Oliviero et al., 2014); cholesterol changes were measured after 12 weeks (Armah et al., 2015).
  • Pitfall – overcooking: Boiling or prolonged heating inactivates myrosinase; complete inactivation cut urinary iberin recovery to 19% (Oliviero et al., 2014).
  • Pitfall – equating iberin with sulforaphane: Most human data concern sulforaphane; assuming iberin shares every effect overstates the evidence.
  • Pitfall – research chemicals: Purified iberin carries no human dosing or safety data.
  • Regulatory status: No marketed drug or dietary supplement product lists iberin as an ingredient; exposure comes from ordinary foods, and chemical suppliers label purified iberin “not for human or veterinary use”.
  • Cost and access: Inexpensive and widely accessible through cruciferous vegetables; not a costly intervention.

Interaction with Foundational Habits

  • Sleep: None known. No study has measured sleep with iberin or glucoiberin-rich foods, and no proposed mechanism suggests disruption; evening crucifer meals may cause bloating in sensitive people.
  • Nutrition: Direct and potentiating. Raw or lightly steamed crucifers, or mustard powder added to cooked ones, maximize release (Okunade et al., 2018); vitamin K content matters for warfarin users; adequate iodine intake offsets theoretical goitrogenic effects.
  • Exercise: Indirect (theoretical). Nrf2 activation could support or blunt training adaptations; a registered trial tests broccoli sprout timing around exercise (NCT07461194). No iberin-specific data exist.
  • Stress management: None known. Iberin’s Nrf2 activity targets oxidative stress at the cellular level, but no study has measured cortisol (the main stress hormone) or perceived stress.

Monitoring Protocol & Defining Success

Before starting a concentrated product, baseline testing establishes reference values: a fasting lipid panel for LDL-C and, in people with thyroid disease or low iodine intake, TSH with free thyroxine. Food-based intake at normal culinary amounts needs no special testing beyond routine health checks. Ongoing monitoring repeats the lipid panel and thyroid tests at 12 weeks, matching the trial duration, then every 6–12 months while concentrated products continue. Success means a stable or lower LDL-C, unchanged thyroid tests and good gastrointestinal tolerance; because no outcome trial of iberin exists, biomarker change is the only measurable signal. Gastrointestinal symptoms are tracked from the first week, since they appear early with concentrated products. Urinary isothiocyanate metabolites confirm absorption but are a research assay.

Biomarker Optimal Functional Range Why Measure It? Context/Notes
LDL-C <100 mg/dL (NCEP ATP III “optimal”) Expected to change: may fall modestly Source: NCEP ATP III, 2001 (National Cholesterol Education Program Adult Treatment Panel III, a government expert panel without revenue from the test). Conventional laboratory reference range: 0–99 mg/dL (varies by laboratory). Fasting preferred; pair with triglycerides.
TSH 0.4–4.0 mIU/L (standard reference range) Safety check: a rise prompts stopping concentrated products Morning draw; pair with free thyroxine. Relevant mainly for thyroid disease or low iodine intake.
Free thyroxine 0.8–1.8 ng/dL (standard reference range) Safety check: confirms thyroid hormone output Same sample as TSH; biotin supplements can distort immunoassays if taken within 2 days of testing.
Urinary isothiocyanate metabolites No established target; track change from own baseline Expected to change: confirms release and absorption Research cyclocondensation assay measuring dithiocarbamates (urinary breakdown products of isothiocyanates) (Ye et al., 2002); not routinely available; spot urine 2–6 hours after intake.

Qualitative markers:

  • Gastrointestinal tolerance (nausea, bloating, stool consistency)
  • Energy levels and general well-being
  • Consistency of crucifer intake and preparation method
  • Signs of thyroid slowing (cold intolerance, fatigue, weight gain) in at-risk users

Emerging Research

  • BETA trial (NCT05367024): Randomized crossover of broccoli versus courgette soup in 26 adults with prediabetes; primary endpoint HbA1c (glycated hemoglobin, a 3-month blood sugar average); completion expected December 2026. Positive: adds a glycemic benefit for glucoiberin-containing broccoli; null: weakens metabolic claims.
  • CRUCIAL-R (NCT07391137): Randomized trial of a high-crucifer diet in 250 people with non-muscle-invasive bladder cancer; primary endpoint 1-year recurrence-free survival; active, completion expected May 2027. Positive: first crucifer outcome benefit in cancer survivors; null: weakens anticancer extrapolation.
  • POW-R Health (NCT06733363): Phase II trial of a crucifer-eating program in 344 bladder cancer survivors; primary endpoint urinary isothiocyanates; recruiting, completion expected February 2029. Positive: shows sustainable dietary exposure is achievable; null: questions food-only delivery.
  • Cruciferous biomarker study (NCT04641026): Oregon State study of broccoli sprouts in 83 adults, measuring sulforaphane metabolites and gut microbiome; completion expected December 2027. Positive: identifies microbiome predictors of release; null: leaves variability unexplained.
  • Missing iberin trials: No registered human trial of purified iberin exists; pharmacokinetic and dose-finding studies would be needed before any supplement form could be evaluated.
  • Nitrile diversion: Gut bacteria producing inactive iberin-nitrile (Bouranis et al., 2021) could weaken the case for food-based delivery in some people.
  • Anti-virulence and analogues: Horseradish iberin as an antibiotic adjuvant (Stanisavljević et al., 2026) and carbohydrate-based iberin analogues (Prieto et al., 2025) could strengthen therapeutic interest but remain preclinical.

Conclusion

Iberin is a natural sulfur compound from cabbage-family vegetables and horseradish, released when these foods are chewed or cut, and a close relative of the much better studied sulforaphane. Laboratory and animal work consistently shows that it switches on the body’s antioxidant and detoxification machinery, dampens inflammation, slows cancer cells in dishes and disrupts how some harmful bacteria coordinate attacks.

In people, however, iberin has never been tested on its own. The human evidence comes from eating broccoli or other cabbage-family vegetables, which supply iberin together with many other active compounds. Within that limit, specially bred broccoli modestly lowered the cholesterol type linked to heart disease, though pooled vegetable studies did not confirm this, and diets rich in these vegetables track with longer life and somewhat lower cancer rates. These links cannot be credited to iberin specifically, so the overall evidence is weak and indirect.

The main known drawbacks come from concentrated relatives rather than iberin itself: digestive discomfort is common with strong sulforaphane products, while worries about thyroid suppression have not been borne out in trials. Several key studies were led by people with commercial stakes, including the inventor of the cholesterol-trial broccoli and the maker of a stabilized sulforaphane product.

For health-focused adults, iberin is best understood as one ingredient of a cabbage-family-rich diet rather than a standalone supplement; no purified product with human safety data exists, and its specific contribution remains uncertain.

Top - Benefits - Risks - Protocol